Related Experiment Video
Updated: May 28, 2026

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects
Published on: September 27, 2024
Natural Products and Antimicrobial Nanoparticles Against Methicillin-Resistant Staphylococcus aureus: Mechanisms,
Abdulaziz M Almuzaini1, Mahmoud Jaber2, Ayman Elbehiry2
1Department of Veterinary Preventive Medicine, College of Veterinary Medicine, Qassim University, Buraydah 51452, Saudi Arabia.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) is a major clinical problem due to its resistance, virulence, and biofilm formation, which diminish antibiotic efficacy. This review explores natural products and antimicrobial nanoparticles (NPs) as alternative and combined strategies for controlling MRSA. Natural compounds, such as plant metabolites, essential oils, antimicrobial peptides, and fungal products, act by disrupting membranes, interfering with cellular processes, and limiting biofilm formation. Antimicrobial NPs, especially metal and metal oxide materials, act through membrane damage, oxidative stress, and metal ion release, enabling activity against resistant bacteria and improving biofilm penetration. Combining natural products with NPs increases stability, delivery, and local activity, enhances antibacterial effects, and reduces effective doses. Green synthesis enables direct integration of bioactive compounds, while nano-delivery platforms optimize solubility and controlled release. Nanotechnology-based applications such as wound dressings, nanocarriers, and multifunctional platforms support localized and sustained treatment and promote tissue repair. Despite these advances, clinical use is still constrained by safety concerns, variability in NP properties, and the lack of standardized evaluation and regulatory frameworks. Overall, combining natural products with antimicrobial NPs offers a practical strategy to augment MRSA treatment, but further progress depends on consistent design, robust safety evaluation, and clinical translation.
Insights
Natural products and antimicrobial nanoparticles offer promising strategies to combat Methicillin-resistant Staphylococcus aureus (MRSA) infections. Combining these approaches enhances efficacy and delivery for improved MRSA treatment.
Area of Science:
- Microbiology
- Nanotechnology
- Pharmacology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses significant clinical challenges due to antibiotic resistance, high virulence, and biofilm formation.
- Existing antibiotic therapies are often ineffective against MRSA, necessitating novel treatment strategies.
- Biofilm formation by MRSA complicates treatment by reducing antibiotic penetration and efficacy.
Purpose of the Study:
- To review natural products and antimicrobial nanoparticles (NPs) as standalone and combined strategies against MRSA.
- To explore the mechanisms of action for natural products and NPs in combating MRSA.
- To assess the potential of nanotechnology-based applications for MRSA treatment and tissue repair.
Main Methods:
- Literature review of natural products (plant metabolites, essential oils, peptides, fungal products) and antimicrobial NPs (metal, metal oxides).
- Analysis of mechanisms including membrane disruption, cellular process interference, oxidative stress, and metal ion release.
- Evaluation of combined strategies, green synthesis, nano-delivery systems, and nanotechnology-based applications.
Main Results:
- Natural products and NPs exhibit antimicrobial activity against MRSA through various mechanisms.
- Combination therapies enhance stability, delivery, and antibacterial effects, reducing required doses.
- Nanotechnology offers platforms for localized, sustained MRSA treatment and tissue repair.
Conclusions:
- Combining natural products with antimicrobial NPs presents a viable strategy to enhance MRSA treatment efficacy.
- Further research is needed to address safety concerns, standardize NP properties, and establish regulatory frameworks for clinical translation.
- Optimized design, rigorous safety evaluation, and clinical validation are crucial for the successful implementation of these novel therapies.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Staphylococcal Skin Infections
Microbial Corrosion
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
